Bitterroot Bio

Pioneering cardio-immunology to transform cardiovascular medicine

Palo Alto, United States · Founded 2021 · $145.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$145.0M
Last Round
$145.0M Series AJun 2023
Rounds
1

About

Bitterroot Bio is pioneering cardio-immunology, which investigates the interplay between the immune system and cardiovascular health, to develop immunotherapies that treat cardiovascular disease rather than only its symptoms. The company builds on immunotherapy success in oncology by targeting immune cells and modulators that drive disease, including elevated CD47 in blood vessel walls that helps harmful cells evade macrophages and contribute to atherosclerotic plaque. Grounded in scientific research and collaboration with cardiologists, Bitterroot aims to slow or prevent plaque formation and transform how these diseases are treated.

Summary

Bitterroot Bio is a Biotech company based in Palo Alto, United States, founded in 2021. It has raised $145.0M in total across 1 round, most recently a $145.0M Series A round in Jun 2023. Investors include ARCH Venture Partners, Deerfield Management and GV.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2023
$145.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bitterroot Bio on Indexed.vc
<a href="https://indexed.vc/companies/bitterroot-bio"><img src="https://indexed.vc/api/badge/company/bitterroot-bio" alt="Bitterroot Bio on Indexed.vc" width="260" height="76" /></a>